Logo image of BTSG

BRIGHTSPRING HEALTH SERVICES (BTSG) Stock Fundamental Analysis

NASDAQ:BTSG - Nasdaq - US10950A1060 - Common Stock - Currency: USD

23.095  +0.17 (+0.76%)

Fundamental Rating

4

Taking everything into account, BTSG scores 4 out of 10 in our fundamental rating. BTSG was compared to 102 industry peers in the Health Care Providers & Services industry. BTSG has a medium profitability rating, but doesn't score so well on its financial health evaluation. While showing a medium growth rate, BTSG is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year BTSG was profitable.
In the past year BTSG had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: BTSG reported negative net income in multiple years.
BTSG had a positive operating cash flow in 4 of the past 5 years.
BTSG Yearly Net Income VS EBIT VS OCF VS FCFBTSG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

Looking at the Return On Assets, with a value of 0.98%, BTSG is in line with its industry, outperforming 50.98% of the companies in the same industry.
BTSG's Return On Equity of 3.39% is in line compared to the rest of the industry. BTSG outperforms 55.88% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.48%, BTSG is in line with its industry, outperforming 52.94% of the companies in the same industry.
BTSG had an Average Return On Invested Capital over the past 3 years of 3.45%. This is significantly below the industry average of 9.53%.
The last Return On Invested Capital (4.48%) for BTSG is above the 3 year average (3.45%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.98%
ROE 3.39%
ROIC 4.48%
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
BTSG Yearly ROA, ROE, ROICBTSG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

BTSG's Profit Margin of 0.49% is in line compared to the rest of the industry. BTSG outperforms 50.00% of its industry peers.
With a Operating Margin value of 2.15%, BTSG perfoms like the industry average, outperforming 49.02% of the companies in the same industry.
In the last couple of years the Operating Margin of BTSG has grown nicely.
BTSG has a Gross Margin of 13.46%. This is in the lower half of the industry: BTSG underperforms 69.61% of its industry peers.
BTSG's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 2.15%
PM (TTM) 0.49%
GM 13.46%
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
BTSG Yearly Profit, Operating, Gross MarginsBTSG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BTSG is destroying value.
BTSG has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, BTSG has more shares outstanding
Compared to 1 year ago, BTSG has an improved debt to assets ratio.
BTSG Yearly Shares OutstandingBTSG Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
BTSG Yearly Total Debt VS Total AssetsBTSG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

BTSG has an Altman-Z score of 2.87. This is not the best score and indicates that BTSG is in the grey zone with still only limited risk for bankruptcy at the moment.
BTSG's Altman-Z score of 2.87 is fine compared to the rest of the industry. BTSG outperforms 65.69% of its industry peers.
The Debt to FCF ratio of BTSG is 19.98, which is on the high side as it means it would take BTSG, 19.98 years of fcf income to pay off all of its debts.
BTSG's Debt to FCF ratio of 19.98 is in line compared to the rest of the industry. BTSG outperforms 41.18% of its industry peers.
A Debt/Equity ratio of 1.48 is on the high side and indicates that BTSG has dependencies on debt financing.
BTSG has a worse Debt to Equity ratio (1.48) than 69.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.48
Debt/FCF 19.98
Altman-Z 2.87
ROIC/WACC0.53
WACC8.4%
BTSG Yearly LT Debt VS Equity VS FCFBTSG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.73 indicates that BTSG should not have too much problems paying its short term obligations.
BTSG has a better Current ratio (1.73) than 61.76% of its industry peers.
A Quick Ratio of 1.37 indicates that BTSG should not have too much problems paying its short term obligations.
BTSG's Quick ratio of 1.37 is in line compared to the rest of the industry. BTSG outperforms 50.98% of its industry peers.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 1.37
BTSG Yearly Current Assets VS Current LiabilitesBTSG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

5

3. Growth

3.1 Past

BTSG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 122.31%, which is quite impressive.
The Revenue has been growing slightly by 1.45% in the past year.
The Revenue has been growing by 20.01% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)122.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.33%
Revenue 1Y (TTM)1.45%
Revenue growth 3Y18.93%
Revenue growth 5Y20.01%
Sales Q2Q%11.7%

3.2 Future

BTSG is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.82% yearly.
Based on estimates for the next years, BTSG will show a small growth in Revenue. The Revenue will grow by 7.12% on average per year.
EPS Next Y49.38%
EPS Next 2Y33.62%
EPS Next 3Y28.91%
EPS Next 5Y25.82%
Revenue Next Year9.62%
Revenue Next 2Y10.72%
Revenue Next 3Y10.75%
Revenue Next 5Y7.12%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BTSG Yearly Revenue VS EstimatesBTSG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B
BTSG Yearly EPS VS EstimatesBTSG Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 0 0.5 1 1.5

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 37.25 indicates a quite expensive valuation of BTSG.
The rest of the industry has a similar Price/Earnings ratio as BTSG.
The average S&P500 Price/Earnings ratio is at 25.91. BTSG is valued slightly more expensive when compared to this.
Based on the Price/Forward Earnings ratio of 23.52, the valuation of BTSG can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BTSG is on the same level as its industry peers.
BTSG's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.85.
Industry RankSector Rank
PE 37.25
Fwd PE 23.52
BTSG Price Earnings VS Forward Price EarningsBTSG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

BTSG's Enterprise Value to EBITDA ratio is in line with the industry average.
BTSG's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 31.71
EV/EBITDA 14.57
BTSG Per share dataBTSG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BTSG's earnings are expected to grow with 28.91% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.75
PEG (5Y)N/A
EPS Next 2Y33.62%
EPS Next 3Y28.91%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BTSG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BRIGHTSPRING HEALTH SERVICES

NASDAQ:BTSG (5/23/2025, 2:30:02 PM)

23.095

+0.17 (+0.76%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-02 2025-05-02/bmo
Earnings (Next)07-31 2025-07-31/bmo
Inst Owners46.78%
Inst Owner Change0.44%
Ins Owners0.56%
Ins Owner Change16.37%
Market Cap4.04B
Analysts84.44
Price Target26.17 (13.31%)
Short Float %12.42%
Short Ratio4.64
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)47.16%
Min EPS beat(2)-2.7%
Max EPS beat(2)97.01%
EPS beat(4)1
Avg EPS beat(4)3.84%
Min EPS beat(4)-40.94%
Max EPS beat(4)97.01%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)1.12%
Min Revenue beat(2)-0.62%
Max Revenue beat(2)2.86%
Revenue beat(4)3
Avg Revenue beat(4)2.37%
Min Revenue beat(4)-0.62%
Max Revenue beat(4)4.83%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.96%
PT rev (3m)14.74%
EPS NQ rev (1m)37.5%
EPS NQ rev (3m)10.91%
EPS NY rev (1m)40.59%
EPS NY rev (3m)18.02%
Revenue NQ rev (1m)2.67%
Revenue NQ rev (3m)2.22%
Revenue NY rev (1m)2.86%
Revenue NY rev (3m)2.11%
Valuation
Industry RankSector Rank
PE 37.25
Fwd PE 23.52
P/S 0.35
P/FCF 31.71
P/OCF 19.8
P/B 2.4
P/tB N/A
EV/EBITDA 14.57
EPS(TTM)0.62
EY2.68%
EPS(NY)0.98
Fwd EY4.25%
FCF(TTM)0.73
FCFY3.15%
OCF(TTM)1.17
OCFY5.05%
SpS66.08
BVpS9.64
TBVpS-7.15
PEG (NY)0.75
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.98%
ROE 3.39%
ROCE 5.67%
ROIC 4.48%
ROICexc 4.54%
ROICexgc 14.07%
OM 2.15%
PM (TTM) 0.49%
GM 13.46%
FCFM 1.1%
ROA(3y)-1.36%
ROA(5y)-0.55%
ROE(3y)-11.56%
ROE(5y)-5.06%
ROIC(3y)3.45%
ROIC(5y)3.56%
ROICexc(3y)3.47%
ROICexc(5y)3.63%
ROICexgc(3y)17.05%
ROICexgc(5y)18.21%
ROCE(3y)4.37%
ROCE(5y)4.5%
ROICexcg growth 3Y-9.4%
ROICexcg growth 5Y19.06%
ROICexc growth 3Y-3.14%
ROICexc growth 5Y18.48%
OM growth 3Y-19.38%
OM growth 5Y5.54%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.88%
GM growth 5Y-5.21%
F-Score6
Asset Turnover1.98
Health
Industry RankSector Rank
Debt/Equity 1.48
Debt/FCF 19.98
Debt/EBITDA 5.59
Cap/Depr 38.81%
Cap/Sales 0.66%
Interest Coverage 1.22
Cash Conversion 45.71%
Profit Quality 222.79%
Current Ratio 1.73
Quick Ratio 1.37
Altman-Z 2.87
F-Score6
WACC8.4%
ROIC/WACC0.53
Cap/Depr(3y)36.76%
Cap/Depr(5y)33.73%
Cap/Sales(3y)0.82%
Cap/Sales(5y)0.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)122.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.33%
EPS Next Y49.38%
EPS Next 2Y33.62%
EPS Next 3Y28.91%
EPS Next 5Y25.82%
Revenue 1Y (TTM)1.45%
Revenue growth 3Y18.93%
Revenue growth 5Y20.01%
Sales Q2Q%11.7%
Revenue Next Year9.62%
Revenue Next 2Y10.72%
Revenue Next 3Y10.75%
Revenue Next 5Y7.12%
EBIT growth 1Y60.42%
EBIT growth 3Y-4.13%
EBIT growth 5Y26.66%
EBIT Next Year51.05%
EBIT Next 3Y23.51%
EBIT Next 5YN/A
FCF growth 1Y-141.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-88.72%
OCF growth 3Y-55.52%
OCF growth 5Y-26.51%